Lisa Kamen

Lisa joins Biohaven with 20+ years of experience within clinical operations, primarily in CNS and most recently also in Oncology. Lisa has held the role of Director of Clinical Operations at two different biotech companies and spent 14 years at Bristol-Myers Squibb where she was managed and oversaw pivotal clinical studies. Lisa led the Abilify Autism to a successful approval for treating irritability associated with autistic disorder in children and adolescents. Lisa holds a bachelor of science degree, with a biology / zoology focus from the University of Rhode Island and Master of Healthcare Administration from Quinnipiac University.